These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23150447)

  • 21. Genome integrity: linking pluripotency and tumorgenicity.
    Deng W; Xu Y
    Trends Genet; 2009 Oct; 25(10):425-7. PubMed ID: 19801173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The commonality of plasticity underlying multipotent tumor cells and embryonic stem cells.
    Postovit LM; Costa FF; Bischof JM; Seftor EA; Wen B; Seftor RE; Feinberg AP; Soares MB; Hendrix MJ
    J Cell Biochem; 2007 Jul; 101(4):908-17. PubMed ID: 17177292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells.
    Chai S; Xu X; Wang Y; Zhou Y; Zhang C; Yang Y; Yang Y; Xu H; Xu R; Wang K
    Oncotarget; 2015 Jun; 6(18):16069-83. PubMed ID: 25965829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential.
    Gao W; Chen L; Ma Z; Du Z; Zhao Z; Hu Z; Li Q
    Gastroenterology; 2013 Sep; 145(3):636-46.e5. PubMed ID: 23747337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer stem cells and the ontogeny of lung cancer.
    Peacock CD; Watkins DN
    J Clin Oncol; 2008 Jun; 26(17):2883-9. PubMed ID: 18539968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells.
    Rodriguez R; Rubio R; Masip M; Catalina P; Nieto A; de la Cueva T; Arriero M; San Martin N; de la Cueva E; Balomenos D; Menendez P; García-Castro J
    Neoplasia; 2009 Apr; 11(4):397-407. PubMed ID: 19308294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian Cancer Stem Cells: Unraveling a Germline Connection.
    Parte SC; Smolenkov A; Batra SK; Ratajczak MZ; Kakar SS
    Stem Cells Dev; 2017 Dec; 26(24):1781-1803. PubMed ID: 29078734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential.
    Justilien V; Regala RP; Tseng IC; Walsh MP; Batra J; Radisky ES; Murray NR; Fields AP
    PLoS One; 2012; 7(4):e35040. PubMed ID: 22545096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.
    Shetzer Y; Molchadsky A; Rotter V
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27235476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung cancer stem cells research. Clues from ontogeny.
    Xu Y; Hu YD
    Saudi Med J; 2009 Nov; 30(11):1381-9. PubMed ID: 19882047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells.
    Würth R; Thellung S; Corsaro A; Barbieri F; Florio T
    Front Endocrinol (Lausanne); 2020; 11():54. PubMed ID: 32153500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras.
    Lee JS; Gil JE; Kim JH; Kim TK; Jin X; Oh SY; Sohn YW; Jeon HM; Park HJ; Park JW; Shin YJ; Chung YG; Lee JB; You S; Kim H
    Biochem Biophys Res Commun; 2008 Jan; 365(3):496-502. PubMed ID: 18021740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.
    Park EK; Lee JC; Park JW; Bang SY; Yi SA; Kim BK; Park JH; Kwon SH; You JS; Nam SW; Cho EJ; Han JW
    Cell Death Dis; 2015 Nov; 6(11):e1964. PubMed ID: 26539911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The side population in human lung cancer cell line NCI-H460 is enriched in stem-like cancer cells.
    Shi Y; Fu X; Hua Y; Han Y; Lu Y; Wang J
    PLoS One; 2012; 7(3):e33358. PubMed ID: 22428030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
    Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
    PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-Methylcholanthrene triggers the differentiation of alveolar tumor cells from canine bronchial basal cells and an altered p53 gene promotes their clonal expansion.
    TenHave-Opbroek AA; Shi XB; Gumerlock PH
    Carcinogenesis; 2000 Aug; 21(8):1477-84. PubMed ID: 10910947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.
    Louie E; Nik S; Chen JS; Schmidt M; Song B; Pacson C; Chen XF; Park S; Ju J; Chen EI
    Breast Cancer Res; 2010; 12(6):R94. PubMed ID: 21067584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells.
    Ghosh Z; Huang M; Hu S; Wilson KD; Dey D; Wu JC
    Cancer Res; 2011 Jul; 71(14):5030-9. PubMed ID: 21646469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes.
    Bhagirath D; Zhao X; West WW; Qiu F; Band H; Band V
    Oncotarget; 2015 Apr; 6(11):9018-30. PubMed ID: 25940703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells.
    Morrison BJ; Steel JC; Morris JC
    PLoS One; 2012; 7(11):e49752. PubMed ID: 23152931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.